Golden House Ltd (TLV:GOHO)
1,055.00
-22.00 (-2.04%)
Sep 10, 2026, 5:24 PM IDT
Golden House Revenue
Golden House had revenue of 12.91M ILS in the quarter ending June 30, 2026, with 16.24% growth. This brings the company's revenue in the last twelve months to 52.70M, up 21.74% year-over-year. In the year 2025, Golden House had annual revenue of 48.85M with 22.69% growth.
Revenue (ttm)
52.70M
Revenue Growth
+21.74%
P/S Ratio
3.17
Revenue / Employee
435.56K
Employees
116
Market Cap
167.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.85M | 9.03M | 22.69% |
| Dec 31, 2024 | 39.82M | -14.48M | -26.66% |
| Dec 31, 2023 | 54.30M | -1.68M | -3.00% |
| Dec 31, 2022 | 55.97M | -237.00K | -0.42% |
| Dec 31, 2021 | 56.21M | -3.80M | -6.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Nissan Medical Industries | 607.36M |
| Rekah Pharmaceutical Industry | 304.04M |
| InterCure | 270.20M |
| BrainsWay | 180.82M |
| Seach Medical Group | 154.32M |